Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

    Limited submission

    NIH's limited competition supports partnerships between resource-limited institutions and designated cancer centers to strengthen cancer research, infrastructure, training, and outreach.

    Browse similar grants
    Cancer Research Grants 2026Limited Submission Grant Opportunities
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: December 25, 2026 (Earliest submission) | January 25, 2027 (Application deadline)

    Funding Amounts: Up to $1.3 million–$1.8 million in direct costs annually per partnership for up to 5 years

    Summary: CAPRI supports partnerships between Resource Limited Institutions and NCI-designated Cancer Centers to strengthen cancer research, infrastructure, workforce development, and outreach.

    Key Information: Each partnership must include an RLI and an NCI-designated Cancer Center, with linked applications from partnering institutions.


    Description

    The National Cancer Institute (NCI), part of NIH, administers CAPRI as a limited-competition U54 cooperative agreement program. It establishes and strengthens mutually beneficial partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers. The program builds sustainable research capacity, improves institutional competitiveness, and supports Early-Stage Investigators and trainees through collaborative research, mentorship, and professional development.

    Joint research projects, conducted primarily at RLIs, may span basic, clinical, translational, prevention, control, behavioral, population, and outreach research. Clinical trials are optional. Partnerships integrate research with coordinated community outreach and education, aiming to generate preliminary data for competitive R01-level applications and extend research benefits nationwide. The broader goals are to reduce cancer risk, incidence, morbidity, and mortality and improve survivors’ quality of life.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.